XBP1 and triple-negative breast carcinoma: Recent studies found that XBP1 depletion from triple negative breast cancer cell models inhibited tumor growth and tumor relapse, and the active form of XBP1 was linked to the activation of HIF1α pathway and angiogenesis, and associated with poor prognosis [26].